Welcure Drugs & Pharmaceuticals Ltd — Results, 29-05-2025: Result

Welcure Drugs & Pharmaceuticals Ltd. has announced a board meeting to approve the financial results for the quarter and half-year. The company reported total revenue of ₹2646 lakh with a profit before tax of ₹278 lakh for the year ended, showing a turnaround from a loss in the previous year. However, the statutory auditor issued a disclaimer of opinion citing multiple issues: unsecured loans of ₹8473 lakh without interest or confirmations; unverified advances to suppliers of ₹1944 lakh; unconfirmed borrowings of ₹12,320 lakh; incomplete documentation for sales; inability to verify inventory valued at ₹14,352 lakh due to lack of evidence; and non-disclosure of MSME payables. These concerns raise questions on the reliability and completeness of financial disclosures, impacting transparency for shareholders. The company appointed Vishakha Agrawal & Associates as Secretarial Auditor for FY 2024-25.